Style | Citing Format |
---|---|
MLA | Yazdanimoghaddam F, et al.. "Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis." Doklady Biochemistry and Biophysics, vol. 518, no. 1, 2024, pp. 452-462. |
APA | Yazdanimoghaddam F, Rezazadeh H, Soltani N, Mehranfard N, Dastgerdi AH, Rad MG, Ghasemi M (2024). Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis. Doklady Biochemistry and Biophysics, 518(1), 452-462. |
Chicago | Yazdanimoghaddam F, Rezazadeh H, Soltani N, Mehranfard N, Dastgerdi AH, Rad MG, Ghasemi M. "Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis." Doklady Biochemistry and Biophysics 518, no. 1 (2024): 452-462. |
Harvard | Yazdanimoghaddam F et al. (2024) 'Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis', Doklady Biochemistry and Biophysics, 518(1), pp. 452-462. |
Vancouver | Yazdanimoghaddam F, Rezazadeh H, Soltani N, Mehranfard N, Dastgerdi AH, Rad MG, et al.. Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis. Doklady Biochemistry and Biophysics. 2024;518(1):452-462. |
BibTex | @article{ author = {Yazdanimoghaddam F and Rezazadeh H and Soltani N and Mehranfard N and Dastgerdi AH and Rad MG and Ghasemi M}, title = {Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis}, journal = {Doklady Biochemistry and Biophysics}, volume = {518}, number = {1}, pages = {452-462}, year = {2024} } |
RIS | TY - JOUR AU - Yazdanimoghaddam F AU - Rezazadeh H AU - Soltani N AU - Mehranfard N AU - Dastgerdi AH AU - Rad MG AU - Ghasemi M TI - Long-Term Gaba Supplementation Regulates Diabetic Gastroenteropathy Through Gaba Receptor/Trypsin-1/Pars/Akt/Cox-2 Axis JO - Doklady Biochemistry and Biophysics VL - 518 IS - 1 SP - 452 EP - 462 PY - 2024 ER - |